KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Cash from Investing Activities (2016 - 2026)

Encompass Health (EHC) has disclosed Cash from Investing Activities for 18 consecutive years, with -$150.1 million as the latest value for Q1 2026.

  • For Q1 2026, Cash from Investing Activities rose 5.3% year-over-year to -$150.1 million; the TTM value through Mar 2026 reached -$756.2 million, down 10.86%, while the annual FY2025 figure was -$764.6 million, 17.04% down from the prior year.
  • Cash from Investing Activities hit -$150.1 million in Q1 2026 for Encompass Health, up from -$239.4 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$104.0 million in Q1 2023 and bottomed at -$239.4 million in Q4 2025.
  • Average Cash from Investing Activities over 5 years is -$164.6 million, with a median of -$161.5 million recorded in 2024.
  • On a YoY basis, Cash from Investing Activities climbed as much as 45.49% in 2022 and fell as far as 40.56% in 2022.
  • Encompass Health's Cash from Investing Activities stood at -$206.4 million in 2022, then decreased by 0.82% to -$208.1 million in 2023, then increased by 2.11% to -$203.7 million in 2024, then fell by 17.53% to -$239.4 million in 2025, then soared by 37.3% to -$150.1 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$150.1 million, -$239.4 million, and -$201.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.